QA: PLIANT THERAPEUTICS INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001746473_2023_PLIANT_THERAPEUTICS_INC.pdf

Logs

Graph

Absolute values for 0001746473, PLIANT THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 340,311,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,486,000
3 remainder_Assets 5,816,000
4 LiabilitiesCurrent 23,913,000
5 LiabilitiesNoncurrent 3,429,000
6 remainder_Liabilities 9,929,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 39,949,000
9 ResearchAndDevelopmentExpense 96,936,000
10 remainder_Expenses 0
11 remainder_Revenues 9,685,000
12 remainder_NetIncome 3,879,000
13 remainder_ComprehensiveNetIncome -1,757,000
  yvar yval
0 Assets 350,613,000
1 Liabilities 37,271,000
2 Expenses 136,885,000
3 Revenues 9,685,000
4 StockholdersEquity 313,342,000
5 NetIncome -123,321,000
6 ComprehensiveNetIncome -124,199,500
7 BaseVar 270,045,000
8 EconomicCapitalRatio 2.14

Edgar->Model Mapping

Feature Distribution

Change over Time